[1] |
田润,李晓芳,王春生,等. 全髋关节置换术后伤口愈合不良危险因素分析[J/CD]. 中华关节外科杂志(电子版), 2020, 14(5): 521-526.
|
[2] |
Abdel MP, Cottino U, Mabry TM. Management of periprosthetic femoral fractures following total hip arthroplasty: a review[J]. Int Orthop, 2015, 39(10): 2005-2010.
|
[3] |
Baryeh K, Sochart DH. Post-operative peri-prosthetic fracture rates following the use of cemented polished taper-slip stems for primary total hip arthroplasty: a systematic review[J]. Arch Orthop Trauma Surg, 2022, 142(12): 4075-4085.
|
[4] |
Dobson PF, Reed MR. Prevention of infection in primary THA and TKA[J]. EFORT Open Rev, 2020, 5(10): 604-613.
|
[5] |
Guo L, Yang Y, An B, et al. Risk factors for dislocation after revision total hip arthroplasty: a systematic review and meta-analysis[J]. Int J Surg, 2017, 38: 123-129.
|
[6] |
Janssen L, Wijnands KAP, Janssen D, et al. Do stem design and surgical approach influence early aseptic loosening in cementless THA?[J]. Clin Orthop Relat Res, 2018, 476(6): 1212-1220.
|
[7] |
邢更彦,张鹏礼,姜川,等. 体外冲击波疗法联合自体骨髓干细胞移植治疗股骨头坏死[J/CD]. 中华关节外科杂志(电子版), 2011, 5(4): 413-418.
|
[8] |
Kawano K, Motomura G, Ikemura S, et al. Long-term hip survival and factors influencing patient-reported outcomes after transtrochanteric anterior rotational osteotomy for osteonecrosis of the femoral head: a minimum 10-year follow-up case series[J]. Mod Rheumatol, 2020, 30(1): 184-190.
|
[9] |
Wang CJ, Cheng JH, Huang CC, et al. Extracorporeal shockwave therapy for avascular necrosis of femoral head[J]. Int J Surg, 2015, 24(Pt B): 184-187.
|
[10] |
Wang Z, Sun QM, Zhang FQ, et al. Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: a meta-analysis[J]. Int J Surg, 2019, 69: 23-31.
|
[11] |
Yue JA, Gao H, Guo X, et al. Fibula allograft propping as an effective treatment for early-stage osteonecrosis of the femoral head: a systematic review[J/OL]. J Orthop Surg Res, 2020, 15(1): 206. DOI: 10.1186/s13018-020-01730-6.
|
[12] |
左荣台,关俊杰,康庆林. 激素性股骨头坏死治疗研究进展[J]. 国际骨科学杂志,2019, 40(3): 160-164.
|
[13] |
Zhao J, He W, Zheng H, et al. Bone regeneration and angiogenesis by co-transplantation of angiotensin II-pretreated mesenchymal stem cells and endothelial cells in early steroid-induced osteonecrosis of the femoral head[J/OL]. Cell Transplant, 2022, 31: 9636897221086965. DOI: 10.1177/09636897221086965.
|
[14] |
Xu H, Wang C, Liu C, et al. Cotransplantation of mesenchymal stem cells and endothelial progenitor cells for treating steroid-induced osteonecrosis of the femoral head[J]. Stem Cells Transl Med, 2021, 10(5): 781-796.
|
[15] |
苟文隆,彭江,卢强,等. 股骨头骨坏死塌陷机制研究进展[J]. 中国矫形外科杂志,2014, 22(7): 621-624.
|
[16] |
田心保,林瑞珠,朱宁. 激素性股骨头缺血性坏死的发病机制[J]. 中国矫形外科杂志,2022, 30(10): 915-919.
|
[17] |
Liu F, Wang W, Yang L, et al. An epidemiological study of etiology and clinical characteristics in patients with nontraumatic osteonecrosis of the femoral head[J/OL]. J Res Med Sci, 2017, 22: 15. DOI: 10.4103/1735-1995.200273.
|
[18] |
Zhao D, Zhang F, Wang B, et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)[J]. J Orthop Translat, 2020, 21: 100-110.
|
[19] |
Boontanapibul K, Steere JT, Amanatullah DF, et al. Diagnosis of osteonecrosis of the femoral head: too little, too late, and independent of etiology[J]. J Arthroplasty, 2020, 35(9): 2342-2349.
|
[20] |
Xu Y, Jiang Y, Xia C, et al. Stem cell therapy for osteonecrosis of femoral head: opportunities and challenges[J]. Regen Ther, 2020, 15: 295-304.
|
[21] |
谢志鸿,彭吾训. 骨髓间充质干细胞治疗股骨头坏死的研究进展[J]. 实用医学杂志,2021, 37(1): 20-24.
|
[22] |
Zakrzewski W, Dobrzyński M, Szymonowicz M, et al. Stem cells: past, present, and future[J/OL]. Stem Cell Res Ther, 2019, 10(1): 68. DOI: 10.1186/s13287-019-1165-5.
|
[23] |
Fu X, Liu G, Halim A, et al. Mesenchymal stem cell migration and tissue repair[J/OL]. Cells, 2019, 8(8): 784. DOI: 10.3390/cells8080784.
|
[24] |
Mao L, Jiang P, Lei X, et al. Efficacy and safety of stem cell therapy for the early-stage osteonecrosis of femoral head: a systematic review and meta-analysis of randomized controlled trials[J/OL]. Stem Cell Res Ther, 2020, 11(1): 445. DOI: 10.1186/s13287-020-01956-5.
|
[25] |
Kang JS, Suh YJ, Moon KH, et al. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression[J/OL]. Stem Cell Res Ther, 2018, 9(1): 274. DOI: 10.1186/s13287-018-1030-y.
|
[26] |
Fujita Y, Kawamoto A. Stem cell-based peripheral vascular regeneration[J]. Adv Drug Deliv Rev, 2017, 120: 25-40.
|
[27] |
Varela-Eirin M, Loureiro J, Fonseca E, et al. Cartilage regeneration and ageing: targeting cellular plasticity in osteoarthritis[J]. Ageing Res Rev, 2018, 42: 56-71.
|
[28] |
Jessen KR, Mirsky R, Arthur-Farraj P. The role of cell plasticity in tissue repair: adaptive cellular reprogramming[J]. Dev Cell, 2015, 34(6): 613-620.
|
[29] |
Mosteiro L, Pantoja C, Alcazar N, et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo[J/OL]. Science, 2016, 354(6315): aaf4445. DOI: 10.1126/science.aaf4445.
|
[30] |
Xu X, Liang Y, Li X, et al. Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regeneration[J/OL]. Biomaterials, 2021, 269: 120539. DOI: 10.1016/j.biomaterials.2020.120539.
|
[31] |
Zhang S, Chuah SJ, Lai RC, et al. MSC exosomes mediate cartilage repair by enhancing proliferation, attenuating apoptosis and modulating immune reactivity[J]. Biomaterials, 2018, 156: 16-27.
|
[32] |
Shi W, Sun M, Hu X, et al. Structurally and functionally optimized silk-fibroin-gelatin scaffold using 3D printing to repair cartilage injury in vitro and in vivo[J/OL]. Adv Mater, 2017, 29(29). DOI: 10.1002/adma.201701089.
|
[33] |
|
[34] |
Zhou M, Xi J, Cheng Y, et al. Reprogrammed mesenchymal stem cells derived from iPSCs promote bone repair in steroid-associated osteonecrosis of the femoral head[J/OL]. Stem Cell Res Ther, 2021, 12(1): 175. DOI: 10.1186/s13287-021-02249-1.
|
[35] |
Li R, Lin QX, Liang XZ, et al. Stem cell therapy for treating osteonecrosis of the femoral head: from clinical applications to related basic research[J/OL]. Stem Cell Res Ther, 2018, 9(1): 291. DOI: 10.1186/s13287-018-1018-7.
|
[36] |
Wu ZY, Sun Q, Liu M, et al. Correlation between the efficacy of stem cell therapy for osteonecrosis of the femoral head and cell viability[J/OL]. BMC Musculoskelet Disord, 2020, 21(1): 55. DOI: 10.1186/s12891-020-3064-4.
|
[37] |
Bacakova L, Zarubova J, Travnickova M, et al. Stem cells: their source, potency and use in regenerative therapies with focus on adipose-derived stem cells - a review[J]. Biotechnol Adv, 2018, 36(4): 1111-1126.
|
[38] |
Zhu ZH, Song WQ, Zhang CQ, et al. Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head[J]. Exp Ther Med, 2016, 12(5): 2843-2850.
|
[39] |
Jin H, Xia B, Yu N, et al. The effects of autologous bone marrow mesenchymal stem cell arterial perfusion on vascular repair and angiogenesis in osteonecrosis of the femoral head in dogs[J]. Int Orthop, 2012, 36(12): 2589-2596.
|
[40] |
Chen C, Qu Z, Yin X, et al. Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: a three-year follow-up study[J]. Mol Med Rep, 2016, 14(5): 4209-4215.
|
[41] |
Mao Q, Jin H, Liao F, et al. The efficacy of targeted intraarterial delivery of concentrated autologous bone marrow containing mononuclear cells in the treatment of osteonecrosis of the femoral head: a five year follow-up study[J]. Bone, 2013, 57(2): 509-516.
|
[42] |
Pan J, Ding Q, Lv S, et al. Prognosis after autologous peripheral blood stem cell transplantation for osteonecrosis of the femoral head in the pre-collapse stage: a retrospective cohort study[J/OL]. Stem Cell Res Ther, 2020, 11(1): 83. DOI: 10.1186/s13287-020-01595-w.
|
[43] |
Lieberman JR. Core decompression for osteonecrosis of the hip[J]. Clin Orthop RelatRes, 2004(418): 29-33.
|
[44] |
Hua KC, Yang XG, Feng JT, et al. The efficacy and safety of core decompression for the treatment of femoral head necrosis: a systematic review and meta-analysis[J/OL]. J Orthop Surg Res, 2019, 14(1): 306. DOI: 10.1186/s13018-019-1359-7.
|
[45] |
Migliorini F, Maffulli N, Eschweiler J, et al. Core decompression isolated or combined with bone marrow-derived cell therapies for femoral head osteonecrosis[J]. Expert Opin Biol Ther, 2021, 21(3): 423-430.
|
[46] |
Serong S, Haversath M, Tassemeier T, et al. Results of advanced core decompression in patients with osteonecrosis of the femoral head depending on age and sex-a prospective cohort study[J/OL]. J Orthop Surg Res, 2020, 15(1): 124. DOI: 10.1186/s13018-020-01643-4.
|
[47] |
Mercier F. Fractones: extracellular matrix niche controlling stem cell fate and growth factor activity in the brain in health and disease[J]. Cell Mol Life Sci, 2016, 73(24): 4661-4674.
|
[48] |
Lee E, Ko JY, Kim J, et al. Osteogenesis and angiogenesis are simultaneously enhanced in BMP2-/ VEGF-transfected adipose stem cells through activation of the YAP/TAZ signaling pathway[J]. Biomater Sci, 2019, 7(11): 4588-4602.
|
[49] |
Maruyama M, Moeinzadeh S, Guzman RA, et al. The efficacy of lapine preconditioned or genetically modified IL4 over-expressing bone marrow-derived mesenchymal stromal cells in corticosteroid-associated osteonecrosis of the femoral head in rabbits[J/OL]. Biomaterials, 2021, 275: 120972. DOI: 10.1016/j.biomaterials.2021.120972.
|
[50] |
Yao X, Yu S, Jing X, et al. PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway[J/OL]. Stem Cell Res Ther, 2020, 11(1): 140. DOI: 10.1186/s13287-020-01658-y.
|
[51] |
Zhang F, Peng W, Zhang J, et al. P53 and Parkin co-regulate mitophagy in bone marrow mesenchymal stem cells to promote the repair of early steroid-induced osteonecrosis of the femoral head[J/OL]. Cell Death Dis, 2020, 11(1): 42. DOI: 10.1038/s41419-020-2238-1.
|
[52] |
Wang C, Xu H, Liu C, et al. CaO2/gelatin oxygen slow-releasing microspheres facilitate tissue engineering efficiency for the osteonecrosis of femoral head by enhancing the angiogenesis and survival of grafted bone marrow mesenchymal stem cells[J]. Biomater Sci, 2021, 9(8): 3005-3018.
|
[53] |
Kawai T, Shanjani Y, Fazeli S, et al. Customized, degradable, functionally graded scaffold for potential treatment of early stage osteonecrosis of the femoral head[J]. J Orthop Res, 2018, 36(3): 1002-1011.
|
[54] |
Maruyama M, Nabeshima A, Pan CC, et al. The effects of a functionally-graded scaffold and bone marrow-derived mononuclear cells on steroid-induced femoral head osteonecrosis[J]. Biomaterials, 2018, 187: 39-46.
|
[55] |
Wang Y, Zhu W, Xiao K, et al. Self-healing and injectable hybrid hydrogel for bone regeneration of femoral head necrosis and defect[J]. Biochem Biophys Res Commun, 2019, 508(1): 25-30.
|
[56] |
Ruytinx P, Proost P, van Damme J, et al. Chemokine-induced macrophage polarization in inflammatory conditions[J/OL]. Front Immunol, 2018, 9: 1930. DOI: 10.3389/fimmu.2018.01930.
|
[57] |
Jiang C, Zhou Z, Lin Y, et al. Astragaloside IV ameliorates steroid-induced osteonecrosis of the femoral head by repolarizing the phenotype of pro-inflammatory macrophages[J/OL]. Int Immunopharmacol, 2021, 93: 107345. DOI: 10.1016/j.intimp.2020.107345.
|
[58] |
Jin S, Meng C, He Y, et al. Curcumin prevents osteocyte apoptosis by inhibiting M1-type macrophage polarization in mice model of glucocorticoid-associated osteonecrosis of the femoral head[J]. J Orthop Res, 2020, 38(9): 2020-2030.
|
[59] |
Wu X, Wang Y, Sun W, et al. Potential roles of extracellular vesicles in osteonecrosis of femoral head: a systematic review[J/OL]. Gene, 2021, 772: 145379. DOI: 10.1016/j.gene.2020.145379.
|
[60] |
Kuang MJ, Huang Y, Zhao XG, et al. Exosomes derived from Wharton’s jelly of human umbilical cord mesenchymal stem cells reduce osteocyte apoptosis in glucocorticoid-induced osteonecrosis of the femoral head in rats via the miR-21-PTEN-AKT signalling pathway[J]. Int J Biol Sci, 2019, 15(9): 1861-1871.
|
[61] |
Li J, Ge Z, Ji W, et al. The proosteogenic and proangiogenic effects of small extracellular vesicles derived from bone marrow mesenchymal stem cells are attenuated in steroid-induced osteonecrosis of the femoral head[J/OL]. Biomed Res Int, 2020, 2020: 4176926. DOI: 10.1155/2020/4176926.
|
[62] |
Fang S, Li Y, Chen P. Osteogenic effect of bone marrow mesenchymal stem cell-derived exosomes on steroid-induced osteonecrosis of the femoral head[J]. Drug Des Devel Ther, 2018, 13: 45-55.
|
[63] |
Zuo R, Kong L, Wang M, et al. Exosomes derived from human CD34 + stem cells transfected with miR-26a prevent glucocorticoid-induced osteonecrosis of the femoral head by promoting angiogenesis and osteogenesis[J/OL]. Stem Cell Res Ther, 2019, 10(1): 321. DOI: 10.1186/s13287-019-1426-3.
|
[64] |
Yuan N, Ge Z, Ji W, et al. Exosomes secreted from hypoxia-preconditioned mesenchymal stem cells prevent steroid-induced osteonecrosis of the femoral head by promoting angiogenesis in rats[J/OL]. Biomed Res Int, 2021, 2021: 6655225. DOI: 10.1155/2021/6655225.
|
[65] |
Moll G, Hoogduijn MJ, Ankrum JA. Editorial: safety, efficacy and mechanisms of action of mesenchymal stem cell therapies[J/OL]. Front Immunol, 2020, 11: 243. DOI: 10.3389/fimmu.2020.00243.
|
[66] |
Daniel-Moreno A, Lamsfus-Calle A, Raju J, et al. CRISPR/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation[J]. Bone Marrow Transplant, 2019, 54(12): 1940-1950.
|
[67] |
Huang XP, Sun Z, Miyagi Y, et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair[J]. Circulation, 2010, 122(23): 2419-2429.
|